We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
+10.22%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$780M
AUM Growth
+$55.8M
Cap. Flow
-$6.3M
Cap. Flow %
-0.81%
Top 10 Hldgs %
37.63%
Holding
130
New
4
Increased
36
Reduced
70
Closed
3

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$7.93M
2
GS icon
Goldman Sachs
GS
+$4.78M
3
ALC icon
Alcon
ALC
+$3.49M
4
BMY icon
Bristol-Myers Squibb
BMY
+$1.16M
5
MRVL icon
Marvell Technology
MRVL
+$738K

Top Sells

Rank Stock Value
1
Z icon
Zillow
Z
+$5.88M
2
ZS icon
Zscaler
ZS
+$5.71M
3
LMT icon
Lockheed Martin
LMT
+$3.4M
4
AAPL icon
Apple
AAPL
+$1.26M
5
TIP icon
iShares TIPS Bond ETF
TIP
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 27.46%
2 Healthcare 26.98%
3 Industrials 9.8%
4 Miscellaneous 8.29%
5 Financials 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$61.9M 7.94%
348,623
-8,002
-2% -$1.26M
VCSH icon
2
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$36.7M 4.7%
451,396
-4,134
-0.9% -$338K
MSFT icon
3
Microsoft
MSFT
$3.81T
$35.8M 4.59%
106,446
-1,982
-2% -$643K
JPM icon
4
JPMorgan Chase
JPM
$951B
$30M 3.84%
189,328
+2,272
+1% +$373K
SYK icon
5
Stryker
SYK
$127B
$24.5M 3.14%
91,555
-765
-0.8% -$201K
JNJ icon
6
Johnson & Johnson
JNJ
$646B
$23.3M 2.99%
136,088
-883
-0.6% -$145K
TMO icon
7
Thermo Fisher Scientific
TMO
$230B
$22.4M 2.87%
33,568
-1,097
-3% -$685K
ECL icon
8
Ecolab
ECL
$80.4B
$20.9M 2.69%
89,286
+701
+0.8% +$158K
ALC icon
9
Alcon
ALC
$34.8B
$19M 2.44%
218,546
+42,336
+24% +$3.49M
MRVL icon
10
Marvell Technology
MRVL
$195B
$18.9M 2.43%
216,537
+9,876
+5% +$738K
PAYX icon
11
Paychex
PAYX
$45.2B
$18.9M 2.42%
138,365
-5,320
-4% -$658K
ABBV icon
12
AbbVie
ABBV
$451B
$17.3M 2.22%
127,734
-2,324
-2% -$275K
STE icon
13
Steris
STE
$22.8B
$14.9M 1.91%
61,261
-380
-0.6% -$86.8K
VMC icon
14
Vulcan Materials
VMC
$35.6B
$14.8M 1.9%
71,493
-1,863
-3% -$361K
RTX icon
15
RTX Corp
RTX
$285B
$13.2M 1.69%
153,589
-9,104
-6% -$793K
WSO icon
16
Watsco Inc
WSO
$12.8B
$13.2M 1.69%
42,061
+945
+2% +$280K
CPRT icon
17
Copart
CPRT
$30.5B
$12.5M 1.6%
330,152
-27,568
-8% -$1.02M
INTC icon
18
Intel
INTC
$473B
$12.3M 1.58%
238,781
-2,573
-1% -$132K
MRK icon
19
Merck
MRK
$366B
$12M 1.54%
156,875
+5,148
+3% +$410K
CAT icon
20
Caterpillar
CAT
$368B
$11.9M 1.52%
57,417
-344
-0.6% -$69.3K
PEP icon
21
PepsiCo
PEP
$193B
$11.6M 1.49%
66,816
+201
+0.3% +$32.8K
CSCO icon
22
Cisco
CSCO
$433B
$11.5M 1.47%
180,948
-1,426
-0.8% -$81.5K
BMY icon
23
Bristol-Myers Squibb
BMY
$136B
$11.4M 1.46%
182,798
+19,758
+12% +$1.16M
HOLX
24
DELISTED
Hologic
HOLX
$11.3M 1.45%
147,811
+1,566
+1% +$115K
CHD icon
25
Church & Dwight Co
CHD
$24B
$10.8M 1.38%
105,050
-4,093
-4% -$371K

Similar funds

LaFleur & Godfrey's Q4 2021 Portfolio in Review

As of Q4 2021, LaFleur & Godfrey held 130 positions worth $780M, up 7.7% from $724M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

LaFleur & Godfrey's Q4 2021 filing shows 4 new, 36 increased, 70 reduced and 3 closed positions. Its largest new stake was Micron Technology: 8,550 shares worth $796K. The largest sale was Zillow, an estimated $5.88M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • LaFleur & Godfrey's largest Q4 2021 buy was Micron Technology: 8,550 shares worth $796K.
  • LaFleur & Godfrey added most to Medtronic in Q4 2021, an estimated $7.93M increase.
  • LaFleur & Godfrey's biggest Q4 2021 reduction was Zscaler, cutting an estimated $5.71M.
  • LaFleur & Godfrey fully exited Zillow in Q4 2021, selling an estimated $5.88M.
  • LaFleur & Godfrey's ten largest holdings make up 38% of its $780M portfolio in Q4 2021.
  • LaFleur & Godfrey opened 4 new positions and closed 3 in Q4 2021.
  • LaFleur & Godfrey's portfolio value rose 7.7% quarter-over-quarter to $780M.

Based on LaFleur & Godfrey's 13F filing for Q4 2021, filed 26 Jan 2022.